TSMC Secures US$20 Billion Approval for Arizona Fab Expansion
TSM•Taiwan Semiconductor Manufacturing Company secured government approval to inject US$20 billion into its Arizona unit, marking its largest overseas investment to date. The funding will expand its Phoenix-area semiconductor fab capacity for advanced 2 nm and 3 nm nodes, bolstering US chip production capabilities.
1. Approval Details
Taiwan’s Department of Investment Review under the Ministry of Economic Affairs formally approved TSMC’s US$20 billion capital injection into its US subsidiary, TSMC Arizona. This regulatory clearance enables the company to proceed with the largest overseas investment in its history.
2. Capital Injection Purpose
The US$20 billion will fund construction of new cleanroom space, procurement of advanced lithography and etch tools, and R&D facilities at the Phoenix campus. Development will focus on high-volume manufacturing of 3 nm and 2 nm process technologies.
3. Strategic Rationale
The expansion aligns with US incentives to onshore semiconductor production and addresses customer demand for diversified supply chains. It also mitigates geopolitical risks by distributing advanced-node capacity outside Asia.
4. Financial and Operational Impact
This investment represents a significant portion of TSMC’s multi-year capital expenditure plan, potentially weighing on near-term free cash flow. In the long term, added US capacity is expected to drive revenue growth and strengthen margins once production commences post-2028.
